Iron absorption and requirements in people living at high altitude
Official title: Iron Balance in Humans Living at High Altitude: Defining Requirements and Optimal Biomarker Thresholds Using a Novel Body Iron Labelling Technique Based on Stable Iron Isotopes.
Run by Swiss Distance University of Applied Sciences · NCT07142590 · Data updated 2026-11-12
This study will test whether healthy adults living at high altitude absorb and retain more dietary iron than adults at lower altitude by giving a small oral dose of a labeled iron and tracking blood changes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Swiss Distance University of Applied Sciences Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Status | Recruiting |
| Started | August 22, 2025 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07142590 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy non-smoking men and women aged 18–45 with BMI 18–25, body weight <70 kg for females or <85 kg for males, plasma ferritin >25 µg/L, normal hemoglobin, and willingness to attend follow-up visits over two years.
✕Probably not a fit
People with anemia, inflammation, chronic diseases affecting iron metabolism, pregnancy or lactation, recent participation in isotope studies, high physical activity, smokers, or those unable to give blood are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will recruit two groups of healthy adults in Switzerland—one living below 1000 m and one above 1500 m—with 60 participants per group (30 men and 30 women). Each participant will receive a single oral dose of stable 57Fe as ferrous sulfate with vitamin C, and blood samples will be collected during the second year at months 12, 16, 20 and 24 to measure isotopic enrichment and iron kinetics. Hemoglobin mass will be measured at two visits using a carbon monoxide rebreathing method, and no other interventions will be given. The aim is to define long-term iron absorption and losses at different altitudes to inform intake recommendations and diagnostic thresholds for iron deficiency.
Why it matters
Potential benefit: If successful, the results could support altitude-adjusted iron intake recommendations and clearer diagnostic thresholds to better prevent and treat iron deficiency in high-altitude populations.
How similar studies have gone: Stable iron isotope methods are well-established for measuring absorption, but long-term iron-balance comparisons between residents at different altitudes are limited and relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Females and males aged 18-45 y * BMI: 18 to 25 kg/m2 * Body weight \<70 kg for females, \<85 kg for males * Plasma ferritin \>25 µg/L * Signed informed consent Exclusion Criteria: * Hb \<12 g/dL (females), Hb \<13 g/dL (males), corrected for altitude using the 2024 WHO guidance values for hemoglobin adjustments * Inflammation (CRP \> 5 mg/L)1 * Plasma ferritin \>150 µg/L for females and \>200 µg/L for males * Chronic disease known to affect iron metabolism * Chronic medications (except for oral contraceptives) * Pregnancy (tested at screening) or intention to become pregnant during the course of the study * Lactation * High physical activity (MET-min/week \> 3000 calculated according to the IPAQ, short version, administered at the screening) * Difficulty with blood withdrawal * Earlier participation in a study using stable iron isotopes or participation in any clinical study within the last 30 days * Smoking * Blood donation, blood transfusion or significant blood loss (more than 400 mL) over the past 6 months * Intention to regularly donate blood during the 2 years duration of the study * No residence in the respective location/altitude for at least the last 2 years * No intention to reside in the respective location/altitude at least for the next 2 years * Participants who are planning to spend an extended period (\>12 weeks) at a different altitude from their residence location * Spending more than 2 nights per week at a different location from residence location * Inability to understand the information sheet and the informed consent form due to cognitive or language reasons
Where it's running
-
Fernfachhochschule Schweiz (FFHS)
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Diego Moretti, Prof. Dr. — Fernfachhochschule Schweiz (FFHS), SUPSI
- Study coordinator: Nora Barloggio
- Email: nora.barloggio@ffhs.ch
- Phone: +41 44 512 10 01
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron absorption from a hydrogel iron supplement with and without breakfast
This study tests how well three low-dose hydrogel iron supplements are absorbed in non-anemic, iron-depleted women, compared with regular ferrous fumarate, using labeled iron to measure absorption.
-
Improving ready-to-use therapeutic foods to help malnourished Kenyan children absorb iron
This project will test whether changing the iron in ready-to-use therapeutic foods helps severely malnourished Kenyan children absorb iron better and recover from anemia.
-
Dietary iron needs for U.S. adults
This project will test how much iron healthy men and premenopausal women ages 18–50 need by giving a safe stable iron isotope and measuring blood levels over 12 weeks.
-
Examining zinc and iron absorption from common beans in young women
This study tests how different types of common beans affect the absorption of zinc and iron in healthy young women.
-
How short-term low oxygen exposure affects the right side of the heart in healthy adults
We test whether short-term reduced oxygen (simulated 2,500 m and 4,000 m) changes right ventricular function in healthy adults at rest and during light exercise.
-
Right-heart response to short-term low oxygen in people with past HAPE
This trial tests whether brief exposure to simulated high altitude (low oxygen) changes right-heart function in adults who previously had high-altitude pulmonary edema (HAPE).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.